Skip to content

An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice

An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00864929
Enrollment
1500
Registered
2009-03-19
Start date
2009-11-30
Completion date
2010-10-31
Last updated
2011-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nosocomial Infection

Keywords

Non-interventional study, Vietnam, inappropriate treatment, nosocomial infection

Brief summary

The present study is a retrospective cohort study on patients who suffered a nosocomial infection in major hospitals in Vietnam. Data relating to patient demography include age, gender; medical history; APACHE II score; background conditions, infection details and antimicrobial therapy; and all-caused mortality, time of hospitalization and intensive care. The investigators hypothesis is that antimicrobial treatment inappropriate is highly dependent on incidence of antibiotic resistant pathogens, nonfermentative Gram-negative bacilli and ESBL-producing enterobacteriaceae spp. Variables are demographic characteristics, background conditions, immunosuppressive therapy, antimicrobial susceptibility and inappropriate treatment is explored as possible predictors of mortality.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient was diagnosed as nosocomial infection defined according to criteria established by the US CDC. The diagnosis criteria for ventilator-associated pneumonia are modified from those established by the American College of Chest Physicians. * Patient received empiric antimicrobial therapy within 24 hour from onset of infection and had antimicrobial susceptibility.

Exclusion criteria

* A patient was in part of a controlled clinical trial for the current infection episode. * Patients with suspected infections by virus or fungus or tuberculosis will be excluded.

Design outcomes

Primary

MeasureTime frame
The number and percentage of subjects with nosocomial infection received appropriate antimicrobial treatment30 days as from onset of nosocomial infection

Secondary

MeasureTime frame
The number and percentage of patients with nosocomial infections received de-escalation therapy30 days as from onset of nosocomial infection
The number and percentage of hospital mortality, the number of days for hospitalization, intensive care among groups of patients who received appropriate or inappropriate antimicrobial treatments30 days as from onset of nosocomial infection
The determinants for inappropriate antimicrobial treatment and mortality.30 days as from onset of nosocomial infection

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026